Senti Biosciences Inc expected to post a loss of 48 cents a share - Earnings Preview

Senti Biosciences Holdings

05/08/2023 03:22

* Senti Biosciences Inc  SNTI.OQ   SNTI.O  is expected
to report
results on August 7 (estimated).
    * The South San Francisco California-based  company is
expected to
report revenue of $500 thousand, according to the mean estimate
from 3 analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Senti Biosciences
Inc is
for a loss of 48 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Senti
Biosciences
Inc is $4​, above​ its last closing price of $0.97. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.43       -0.43      -0.42     Beat    3.1
 Dec. 31 2023  -0.45       -0.44      -0.42     Beat    4
 Sep. 30 2022  -0.46       -0.46      -0.38     Beat    16.8​
 ​​                                                     
                                                        ​
 This summary was machine generated August 5 at 02:22 GMT.  All
figures in US dollars  unless otherwise stated